

A recent study highlights that central obesity, specifically belly fat, is a stronger predictor of colorectal cancer (CRC) risk than general body mass index (BMI). This research, conducted on 460,784 participants from the UK Biobank, challenges the reliance on BMI alone for assessing obesity-related cancer risk and emphasizes the importance of waist-to-hip ratio (WHR) and waist circumference (WC) in determining colorectal cancer risk.
The study found that an increase in WHR was associated with a higher risk of CRC, with a hazard ratio (HR) of 1.18 per standard deviation increase, compared to 1.10 for BMI. Even after adjusting for BMI, the link between WHR and CRC risk remained significant. In contrast, after adjusting for WHR, the association between BMI and CRC risk weakened considerably. This suggests that belly fat, as indicated by WHR, plays a much more significant role in CRC risk than overall body weight as measured by BMI.
Importantly, WHR was strongly correlated with both colon and rectal cancer risks in both men and women, while BMI showed little to no significant correlation, especially in women and for rectal cancer. This finding suggests that relying on BMI alone may not provide an accurate risk assessment for colorectal cancer, especially when it comes to central obesity.
The results advocate for the inclusion of WHR and WC as key tools in assessing obesity and CRC risk, alongside BMI. Incorporating these measurements could improve early detection and prevention strategies for colorectal cancer, a leading cause of cancer-related deaths globally. As the prevalence of obesity continues to rise, understanding the role of central obesity in CRC risk becomes increasingly crucial in public health.
This study, led by Fatemeh Safizadeh from the German Cancer Research Center, also highlights the limitations of using single baseline measurements for obesity and emphasizes the need for more comprehensive research on how changes in obesity patterns over time influence cancer risk. For healthcare professionals, this research supports a more nuanced approach to assessing obesity, which could lead to more effective prevention and management strategies for colorectal cancer and other obesity-related diseases.
More Information: Safizadeh, F., Mandic, M., Schöttker, B. et al. Central obesity may account for most of the colorectal cancer risk linked to obesity: evidence from the UK Biobank prospective cohort. Int J Obes (2024). https://doi.org/10.1038/s41366-024-01680-7
more recommended stories
Brisk Walking: A 15-Minute Daily Habit That Reduces Mortality in Underserved Populations
A powerful yet simple intervention A.
Vaping and Teen Smoking: UK Study Warns of Rising Risks
A new study published in Tobacco.
Targeting Cancer Cell Memory Boosts Chemotherapy
Researchers double chemotherapy effectiveness through chromatin.
PFAS Exposure Linked to Increased Type 2 Diabetes Risk
Investigating the Metabolic Impact of Forever.
Gecko-Inspired Nanoparticles Offer New Direction in Localized Cancer Therapy
Nature-Inspired Nanoparticles Deliver Precision Chemotherapy Researchers.
Staphylococcus Shows Complex Enzyme Redundancy, Study Finds
A Bacterial Pathogen That Refuses to.
Can Routine Vaccines Help Combat Antibiotic Resistance?
A growing body of evidence now.
T-bet and the Genetic Control of Memory B Cell Differentiation
In a major advancement in immunology,.
Ultra-Processed Foods May Harm Brain Health in Children
Ultra-Processed Foods Linked to Cognitive and.
Parkinson’s Disease Care Advances with Weekly Injectable
A new weekly injectable formulation of.
Leave a Comment